Topical administration of tranexamic acid in primary total knee replacement.

Main Article Content

Agustin Dauria
Hector Mario Depetris

Abstract

IntroductionTotal knee replacement is associated with extensive postoperative blood loss.Tranexamic acid is synthetic antifibrinolytic agent that, in the last few years, has been successfully used intravenously to reduce bleeding after total knee replacement. However, topical application of tranexamic acid in total knee replacement remains largely unexplored.MethodsWe conducted a retrospective study of 117 total knee primary replacements, where 63 of them received topical tranexamic acid, and the remaining 54 replacements in whom no tranexamic acid was used. A comparison analysis was made, capturing results of blood transfusion rates, postoperative hemoglobin levels (24 and 48 hs), number of changed bandages, associated comorbidities and complications.ResultsTranexamic acid reduced the blood tranfusion rate by 43.9% when compared with the group without tranexamic. We also found, that  the same group, resulted in a lower decline in postoperative hemoglobin levels (24 hs) by 2,12 gr/dl. There was no complications in both groups.ConclusionsTopically applied  tranexamic acid was effective in reducing the need for blood transfusion following total knee replacement, without additional adverse effects.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
Dauria, A., & Depetris, H. M. (2018). Topical administration of tranexamic acid in primary total knee replacement. Revista De La Asociación Argentina De Ortopedia Y Traumatología, 83(1), 05-11. https://doi.org/10.15417/697
Section
Clinical Research
Author Biographies

Agustin Dauria, Clinica Depetris de Cadera y Rodilla

Medico Staff en Ortopedia y Traumatologia en Clinica Depetris

Hector Mario Depetris, Clinica Depetris de Cadera y Rodilla

Director Medico y Jefe de Servicio de Clinica Depetris de Cadera y Rodilla

References

1-Wong J, Abrishami A, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized control trial. J Bone Joint Surg 2010;92;2503.

2-Li B, Wen Y, Wu H et al. The effect of tourniquet use on hidden blood loss in total knee arthroplasty. Int Orthop 2009;33;1263-1268.

3-Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010;18;132.

4-Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg 2012;94;1153-1159.

5-Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusión rates in total hip and knee arthroplasty. J Arthroplasty 2014;29;681-684.

6-Dahuja A, Dahuja G, Jaswal V, Sandhu K. A prospective study on role of tranexámico acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty 2014;29;733-735.

7-Alshryda S,Mason J, Vaghela M, et al.Topical (Intra-Articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement. J Bone Joint Surg 2013;95; 1961-1968.

8-Patel VP, Walsh M, Sehgal B, et al. Factors associated with prolongued wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg 2007;89;33

9- Serrano Mateo L,Goudarz Mehdikhani K, Cáceres L, Lee YY, Gonzalez Della Valle A.Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplasty 2016;31;1449-1452.

10-Martin J.G, Casatt K.B, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH.. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty 2014;29;889-894.

11-Georgiadis A.G, Muh S.J, Silverton D.O, Weir RM, Laker MW. A prospective double blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28;78-82.

12- Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg 2014;96;272-278.

13-Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg 1999; 81:2.

14- Chimento GF, Huff T, Lockwood O Jr, Meyer M, Brandner L, Babin S.An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;74-77.

15-Moskal JT, Harris RN, Capps SG. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplasty 2015 (30);365-368.

16- Samujh C, Falls TD, Wessel R, Smith L, Malkani A. Decreased blood transfusion following revision total knee arthroplasty using tranexamic acid. J Arthroplasty 2014;29;182-185.

17- Aguilera X,Videla S, Almenara M, et al. Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop Belga 2012;78:68.